The only way to safeguard antibiotic use is to develop faster diagnostics at the point of care. Our solution uses NANOPLEX™ technology to rapidly identify bacterial infection within 15 minutes.
NANOPLEX enables bacterial ID and enumeration at the point of care; key information for at risk demographics (e.g. pregnant women and elderly).
- Antimicrobial stewardship
- Microbial diagnostics
- Infection prevention
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
- Market entry
- Marketed product
- Joint Venture
Infectious disease area:
We are interested in collaborations with academic groups, antibiotic and diagnostic developers.
FluoretiQ is developing the NANOPLEX technology platform to reduce the time to correctly diagnose bacterial infections from 2 days to 15 mins.
NANOPLEX™ has potential applications in: • Urinary Tract Infection • Antibiotic Susceptibility Testing • Sexually Transmitted Diseases • Veterinary • Food/ Drink Quality Control and Quality Assurance • Oncology